Technical Analysis for ZSAN - Zosano Pharma Corporation

Grade Last Price % Change Price Change
grade F 2.26 0.44% 0.01
ZSAN closed up 0.44 percent on Thursday, January 17, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical ZSAN trend table...

Date Alert Name Type % Chg
Jan 17 20 DMA Resistance Bearish 0.00%
Jan 17 Outside Day Range Expansion 0.00%
Jan 17 Wide Bands Range Expansion 0.00%
Jan 16 Wide Bands Range Expansion 0.44%
Jan 16 Down 3 Days in a Row Weakness 0.44%
Jan 16 Down 4 Days in a Row Weakness 0.44%
Jan 16 Down 5 Days in a Row Weakness 0.44%
Jan 15 Wide Bands Range Expansion -3.42%
Jan 15 Down 3 Days in a Row Weakness -3.42%
Jan 15 Down 4 Days in a Row Weakness -3.42%

Older signals for ZSAN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Zosano Pharma Corporation, a clinical stage specialty pharmaceutical company, develops drug formulations for the treatment of various indications. The company delivers formulations through the skin using its proprietary transdermal microneedle patch system. Its lead product candidates comprise Weekly ZP-PTH, a proprietary formulation of parathyroid hormone that has completed a Phase I clinical study for the treatment of severe osteoporosis in women; ZP-Glucagon, a proprietary formulation of glucagon, which has completed a Phase I study for the emergency treatment of severe hypoglycemia; and ZP-Triptan, a proprietary formulation of zolmitriptan that has completed preclinical animal studies for the treatment of migraine. Zosano Pharma Corporation has a strategic partnership and license agreement with Novo Nordisk A/S to develop a microneedle patch product to administer semaglutide for the treatment of type 2 diabetes. The company was founded in 2006 and is headquartered in Fremont, California.
Is ZSAN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 25.7
52 Week Low 1.85
Average Volume 114,753
200-Day Moving Average 3.9361
50-Day Moving Average 3.2227
20-Day Moving Average 2.4505
10-Day Moving Average 2.575
Average True Range 0.2627
ADX 28.34
+DI 18.379
-DI 28.816
Chandelier Exit (Long, 3 ATRs ) 2.8419
Chandelier Exit (Short, 3 ATRs ) 2.6381
Upper Bollinger Band 3.1066
Lower Bollinger Band 1.7944
Percent B (%b) 0.35
BandWidth 53.548255
MACD Line -0.2271
MACD Signal Line -0.2454
MACD Histogram 0.0183
Fundamentals Value
Market Cap 88.65 Million
Num Shares 39.2 Million
EPS -1.28
Price-to-Earnings (P/E) Ratio -1.77
Price-to-Sales 0.00
Price-to-Book 1.29
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.77
Resistance 3 (R3) 2.80 2.66 2.69
Resistance 2 (R2) 2.66 2.53 2.65 2.66
Resistance 1 (R1) 2.46 2.45 2.39 2.43 2.63
Pivot Point 2.32 2.32 2.29 2.31 2.32
Support 1 (S1) 2.12 2.19 2.05 2.09 1.89
Support 2 (S2) 1.98 2.11 1.97 1.86
Support 3 (S3) 1.78 1.98 1.84
Support 4 (S4) 1.75